CFI-rs7356506 is a genetic protective factor for acute anterior uveitis in Chinese patients

British Journal of Ophthalmology

Volumn 98, Issue 11, 2014, Pages 1592-1596

  Wang, Yuqin ^a   Huang, Xiu Feng ^a   Yang, Ming Ming ^b,c   Cai, Wei Jun ^a   Zheng, Mei Qin ^a   Mao, Guangyun ^a,d,e   Pang, Chi Pui ^c   Jin, Zi Bing ^a  

^a EYE HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d WENZHOU MEDICAL UNIVERSITY   (China)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR I; HLA B27 ANTIGEN; MEMBRANE COFACTOR PROTEIN; CD46 PROTEIN, HUMAN; CFI PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ALLELE; ANKYLOSING SPONDYLITIS; ARTICLE; CASE CONTROL STUDY; CD46 GENE; CFI GENE; CHILD; CHINESE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENOTYPE; HOMOZYGOSITY; HUMAN; IRIDOCYCLITIS; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; ACUTE DISEASE; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; ETHNOLOGY; GENETICS; GENOTYPING TECHNIQUE; MIDDLE AGED; UVEITIS, ANTERIOR;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTIGENS, CD46; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHILD; CHINA; COMPLEMENT FACTOR I; FEMALE; GENOTYPING TECHNIQUES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; UVEITIS, ANTERIOR;

EID: 84910011204     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2014-305296     Document Type: Article

References (22)

1. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005;140:509-16.
2. Chang JH, Wakefield D. Uveitis: a global perspective. Ocul Immunol Inflamm 2002;10:263-79.
3. Nussenblatt RB, Gery I. Experimental autoimmune uveitis and its relationship to clinical ocular inflammatory disease. J Autoimmun 1996;9:575-85.
4. Monnet D, Breban M, Hudry C, et al. Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases. Ophthalmology 2004;111:802-9.
5. Walport MJ. Complement. Second of two parts. N Engl J Med 2001;344:1140-4.
6. Walport MJ. Complement. First of two parts. N Engl J Med 2001;344:1058-66.
7. Jha P, Bora PS, Bora NS. The role of complement system in ocular diseases including uveitis and macular degeneration. Mol Immunol 2007;44:3901-8.
8. Read RW, Szalai AJ, Vogt SD, et al. Genetic deficiency of C3 as well as CNS-targeted expression of the complement inhibitor sCrry ameliorates experimental autoimmune uveoretinitis. Exp Eye Res 2006;82:389-94.
9. Yang MM, Lai TY, Tam PO, et al. Association of C2 and CFB polymorphisms with anterior uveitis. Invest Ophthalmol Vis Sci 2012;53:4969-74.
10. Yang MM, Lai TY, Tam PO, et al. Association of CFH and SERPING1 polymorphisms with anterior uveitis. Br J Ophthalmol 2013;97:1475-80.
11. Yang MM, Lai TY, Luk FO, et al. The roles of genetic factors in uveitis and their clinical significance. Retina 2014;34:1-11.
12. Christie DL, Gagnon J. Amino acid sequence of the Bb fragment from complement Factor B. Sequence of the major cyanogen bromide-cleavage peptide (CB-II) and completion of the sequence of the Bb fragment. Biochem J 1983;209:61-70.
13. Ault BH. Factor H and the pathogenesis of renal diseases. Pediatr Nephrol 2000;14:1045-53.
14. Noris M, Remuzzi G. Overview of complement activation and regulation. Semin Nephrol 2013;33:479-92.
15. Lublin DM, Liszewski MK, Post TW, et al. Molecular cloning and chromosomal localization of human membrane cofactor protein (MCP). Evidence for inclusion in the multigene family of complement-regulatory proteins. J Exp Med 1988;168:181-94.
16. Riley-Vargas RC, Gill DB, Kemper C, et al. CD46: expanding beyond complement regulation. Trends Immunol 2004;25:496-503.
17. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
18. Buetow KH, Edmonson M, MacDonald R, et al. High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc Natl Acad Sci USA 2001;98:581-4.
19. Bora NS, Jha P, Bora PS. The role of complement in ocular pathology. Semin Immunopathol 2008;30:85-95.
20. Vyse TJ, Morley BJ, Bartok I, et al. The molecular basis of hereditary complement factor I deficiency. J Clin Invest 1996;97:925-33.
21. Fremeaux-Bacchi V, Dragon-Durey MA, Blouin J, et al. Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome. J Med Genet 2004;41:e84.
22. van de Ven JP, Nilsson SC, Tan PL, et al. A functional variant in the CFI gene confers a high risk of age-related macular degeneration. Nat Genet 2013;45:813-17.